Estradiol reduces ferrous citrate complex-induced NOS2 up-regulation in cerebral endothelial cells by interfering the nuclear factor kappa B transactivation through an estrogen receptor β-mediated pathway

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Chen, Li Ching ^a   Lee, Wen Sen ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; BRAIN; CHROMATIN IMMUNOPRECIPITATION; DNA PRIMERS; ENDOTHELIAL CELLS; ESTRADIOL; ESTROGEN RECEPTOR BETA; FERROUS COMPOUNDS; GENE EXPRESSION REGULATION; LUCIFERASES; MICE; MICE, INBRED BALB C; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; TRANSCRIPTIONAL ACTIVATION;

EID: 84893443116     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084320     Document Type: Article

References (62)

1. Rothoerl RD, Ringel F (2007) Molecular mechanisms of cerebral vasospasm following aneurysmal SAH. Neurol Res 29: 636-642. (Pubitemid 350086058)
2. Sehba FA, Bederson JB (2006) Mechanisms of acute brain injury after subarachnoid hemorrhage. Neurol Res 28: 381-398. (Pubitemid 43967786)
3. Mocco J, Zacharia BE, Komotar RJ, Connolly ES Jr (2006) A review of current and future medical therapies for cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Neurosurg Focus 21: E9.
4. Horky LL, Pluta RM, Boock RJ, Oldfield EH (1998) Role of ferrous iron chelator 2,2′-dipyridyl in preventing delayed vasospasm in a primate model of subarachnoid hemorrhage. J Neurosurg 88: 298-303. (Pubitemid 28063604)
5. Janjua N, Mayer SA (2003) Cerebral vasospasm after subarachnoid hemorrhage. Curr Opin Crit Care 9: 113-119. (Pubitemid 36408129)
6. Hentze MW, Muckenthaler MU, Andrews NC (2004) Balancing acts: molecular control of mammalian iron metabolism. Cell 117: 285-297. (Pubitemid 38534536)
7. Bishop GM, Robinson SR (2001) Quantitative analysis of cell death and ferritin expression in response to cortical iron: implications for hypoxia-ischemia and stroke. Brain Res 907: 175-187. (Pubitemid 32595527)
8. Bidmon HJ, Emde B, Oermann E, Kubitz R, Witte OW, et al. (2001) Heme oxygenase-1 (HSP-32) and heme oxygenase-2 induction in neurons and glial cells of cerebral regions and its relation to iron accumulation after focal cortical photothrombosis. Exp Neurol 168: 1-22. (Pubitemid 32195254)
9. Ishimaru H, Ishikawa K, Ohe Y, Takahashi A, Tatemoto K, et al. (1996) Activation of iron handling system within the gerbil hippocampus after cerebral ischemia. Brain Res 726: 23-30. (Pubitemid 26292226)
10. Kondo Y, Ogawa N, Asanuma M, Ota Z, Mori A (1995) Regional differences in late-onset iron deposition, ferritin, transferrin, astrocyte proliferation, and microglial activation after transient forebrain ischemia in rat brain. J Cereb Blood Flow Metab 15: 216-226.
11. Palmer C, Menzies SL, Roberts RL, Pavlick G, Connor JR (1999) Changes in iron histochemistry after hypoxic-ischemic brain injury in the neonatal rat. J Neurosci Res 56: 60-71. (Pubitemid 29190617)
12. Ong WY, Ling SF, Yeo JF, Chiueh CC, Farooqui AA (2005) Injury and recovery of pyramidal neurons in the rat hippocampus after a single episode of oxidative stress induced by intracerebroventricular injection of ferrous ammonium citrate. Reprod Nutr Dev 45: 647-662.
13. Edwards DH, Byrne JV, Griffith TM (1992) The effect of chronic subarachnoid hemorrhage on basal endothelium-derived relaxing factor activity in intrathecal cerebral arteries. J Neurosurg 76: 830-837.
14. Onoue H, Kaito N, Akiyama M, Tomii M, Tokudome S, et al. (1995) Altered reactivity of human cerebral arteries after subarachnoid hemorrhage. J Neurosurg 83: 510-515.
15. Grasso G (2004) An overview of new pharmacological treatments for cerebrovascular dysfunction after experimental subarachnoid hemorrhage. Brain Res Brain Res Rev 44: 49-63.
16. Asano T (1999) Oxyhemoglobin as the principal cause of cerebral vasospasm: a holistic view of its actions. Crit Rev Neurosurg 9: 303-318.
17. Suhardja A (2004) Mechanisms of disease: roles of nitric oxide and endothelin-1 in delayed cerebral vasospasm produced by aneurysmal subarachnoid hemorrhage. Nat Clin Pract Cardiovasc Med 1: 110-116; quiz 112 p following 116.
18. Young HM, O'Brien AJ, Furness JB, Ciampoli D, Hardwick JP, et al. (1997) Relationships between NADPH diaphorase staining and neuronal, endothelial, and inducible nitric oxide synthase and cytochrome P450 reductase immuno-reactivities in guinea-pig tissues. Histochem Cell Biol 107: 19-29. (Pubitemid 27092029)
19. Berra LV, Carcereri De Prati A, Suzuki H, Pasqualin A (2007) The role of constitutive and inducible nitric oxide synthase in the human brain after subarachnoid hemorrhage. J Neurosurg Sci 51: 1-9. (Pubitemid 46846447)
20. Hanggi D, Steiger HJ (2006) Nitric oxide in subarachnoid haemorrhage and its therapeutics implications. Acta Neurochir (Wien) 148: 605-613; discussion 613.
21. Vijay A, Santhanam R, Katusic ZS (2006) Genetic modification of cerebral arterial wall: implications for prevention and treatment of cerebral vasospasm. Neurol Res 28: 759-768. (Pubitemid 44656102)
22. Aladag MA, Turkoz Y, Parlakpinar H, Ozen H, Egri M, et al. (2009) Melatonin Ameliorates Cerebral Vasospasm After Experimental Subarachnoidal Haemorrhage Correcting Imbalance of Nitric Oxide Levels in Rats. Neurochem Res.
23. Osuka K, Watanabe Y, Usuda N, Atsuzawa K, Yoshida J, et al. (2009) Modification of Endothelial Nitric Oxide Synthase through AMPK after Experimental Subarachnoid Hemorrhage. J Neurotrauma.
24. Ayer RE, Zhang JH (2008) Oxidative stress in subarachnoid haemorrhage: significance in acute brain injury and vasospasm. Acta Neurochir Suppl 104: 33-41.
25. Pluta RM (2005) Delayed cerebral vasospasm and nitric oxide: review, new hypothesis, and proposed treatment. Pharmacol Ther 105: 23-56.
26. Love BB (1994) Stroke in women. Hawaii Med J 53: 258-259.
27. de Rooij NK, Linn FH, van der Plas JA, Algra A, Rinkel GJ (2007) Incidence of Subarachnoid Haemorrhage: A systematic review with emphasis on region, age, gender and time trends. J Neurol Neurosurg Psychiatry.
28. Mukhopadhyay S, Mukherjee TK (2005) Bridging advanced glycation end product, receptor for advanced glycation end product and nitric oxide with hormonal replacement/estrogen therapy in healthy versus diabetic postmenopausal women: a perspective. Biochim Biophys Acta 1745: 145-155. (Pubitemid 41207888)
29. Li X, Geary GG, Gonzales RJ, Krause DN, Duckles SP (2004) Effect of estrogen on cerebrovascular prostaglandins is amplified in mice with dysfunctional NOS. Am J Physiol Heart Circ Physiol 287: H588-594. (Pubitemid 38955288)
30. Shih HC, Lin CL, Lee TY, Lee WS, Hsu C (2006) 17beta-Estradiol inhibits subarachnoid hemorrhage-induced inducible nitric oxide synthase gene expression by interfering with the nuclear factor kappa B transactivation. Stroke 37: 3025-3031.
31. Chen LC, Hsu C, Chiueh CC, Lee WS (2012) Ferrous citrate up-regulates the NOS2 through nuclear translocation of NFkappaB induced by free radicals generation in mouse cerebral endothelial cells. PLoS One 7: e46239.
32. Xu J, He L, Ahmed SH, Chen SW, Goldberg MP, et al. (2000) Oxygen-glucose deprivation induces inducible nitric oxide synthase and nitrotyrosine expression in cerebral endothelial cells. Stroke 31: 1744-1751. (Pubitemid 30437532)
33. Chen LC, Liu YC, Liang YC, Ho YS, Lee WS (2009) Magnolol inhibits human glioblastoma cell proliferation through upregulation of p21/Cip1. J Agric Food Chem 57: 7331-7337.
34. Ho PY, Zhong WB, Ho YS, Lee WS (2006) Terbinafine inhibits endothelial cell migration through suppression of the Rho-mediated pathway. Mol Cancer Ther 5: 3130-3138.
35. Wilkinson DS, Ogden SK, Stratton SA, Piechan JL, Nguyen TT, et al. (2005) A direct intersection between p53 and transforming growth factor beta pathways targets chromatin modification and transcription repression of the alpha-fetoprotein gene. Mol Cell Biol 25: 1200-1212. (Pubitemid 40165825)
36. West KA, Brognard J, Clark AS, Linnoila IR, Yang X, et al. (2003) Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells. J Clin Invest 111: 81-90. (Pubitemid 36134851)
37. Chen CS, Lee CH, Hsieh CD, Ho CT, Pan MH, et al. (2010) Nicotine-induced human breast cancer cell proliferation attenuated by garcinol through down-regulation of the nicotinic receptor and cyclin D3 proteins. Breast Cancer Res Treat.
38. Shih YL, Liu HC, Chen CS, Hsu CH, Pan MH, et al. (2010) Combination treatment with luteolin and quercetin enhances antiproliferative effects in nicotine-treated MDA-MB-231 cells by down-regulating nicotinic acetylcholine receptors. J Agric Food Chem 58: 235-241.
39. Qi WN, Chaiyakit P, Cai Y, Allen DM, Chen LE, et al. (2004) NF-kappaB p65 involves in reperfusion injury and iNOS gene regulation in skeletal muscle. Microsurgery 24: 316-323. (Pubitemid 38988582)
40. Clark JF, Sharp FR (2006) Bilirubin oxidation products (BOXes) and their role in cerebral vasospasm after subarachnoid hemorrhage. J Cereb Blood Flow Metab 26: 1223-1233. (Pubitemid 44435238)
41. Suzuki H, Muramatsu M, Kojima T, Taki W (2003) Intracranial heme metabolism and cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 34: 2796-2800. (Pubitemid 37517744)
42. Van Bergen P, Rauhala P, Spooner CM, Chiueh CC (1999) Hemoglobin and iron-evoked oxidative stress in the brain: protection by bile pigments, manganese and S-nitrosoglutathione. Free Radic Res 31: 631-640.
43. Chen TY, Tsai KL, Lee TY, Chiueh CC, Lee WS, et al. (2010) Sex-specific role of thioredoxin in neuroprotection against iron-induced brain injury conferred by estradiol. Stroke 41: 160-165.
44. Bertuglia S, Giusti A (2005) Microvascular oxygenation and oxidative stress during postischemic reperfusion. PO2, ROS, and NO during reperfusion. Adv Exp Med Biol 566: 23-29. (Pubitemid 43779480)
45. Shacter E (2000) Quantification and significance of protein oxidation in biological samples. Drug Metab Rev 32: 307-326.
46. Kwan AL, Solenski NJ, Kassell NF, Lee KS (1997) Inhibition of nitric oxide generation and lipid peroxidation attenuates hemolysate-induced injury to cerebrovascular endothelium. Acta Neurochir (Wien) 139: 240-247; discussion 247-248.
47. Stirone C, Duckles SP, Krause DN, Procaccio V (2005) Estrogen increases mitochondrial efficiency and reduces oxidative stress in cerebral blood vessels. Mol Pharmacol 68: 959-965. (Pubitemid 41345787)
48. Barros MH, Netto LE, Kowaltowski AJ (2003) H(2)O(2) generation in Saccharomyces cerevisiae respiratory pet mutants: effect of cytochrmoe c. Free Radic Biol Med 35: 179-188. (Pubitemid 36835918)
49. Chen Q, Vazquez EJ, Moghaddas S, Hoppel CL, Lesnefsky EJ (2003) Production of reactive oxygen species by mitochondria: central role of complex III. J Biol Chem 278: 36027-36031. (Pubitemid 37139922)
50. Zhou ML, Shi JX, Hang CH, Cheng HL, Qi XP, et al. (2007) Potential contribution of nuclear factor-kappaB to cerebral vasospasm after experimental subarachnoid hemorrhage in rabbits. J Cereb Blood Flow Metab 27: 1583-1592 (Pubitemid 47301442)
51. Kuo PC, Abe K, Schroeder RA (2000) Superoxide enhances interleukin 1 beta-mediated transcription of the hepatocyte-inducible nitric oxide synthase gene. Gastroenterology 118: 608-618. (Pubitemid 30140860)
52. Utkan T, Sarioglu Y, Kaya T, Akgun M, Goksel M, et al. (1996) Effect of deferoxamine and sympathectomy on vasospasm following subarachnoid hemorrhage. Pharmacology 52: 353-361. (Pubitemid 26276511)
53. Luo Z, Harada T, London S, Gajdusek C, Mayberg MR (1995) Antioxidant and iron-chelating agents in cerebral vasospasm. Neurosurgery 37: 1154-1158; discussion 1158-1159.
54. Ono S, Date I, Onoda K, Shiota T, Ohmoto T, et al. (1998) Decoy administration of NF-kappaB into the subarachnoid space for cerebral angiopathy. Hum Gene Ther 9: 1003-1011. (Pubitemid 28236509)
55. Ghosh S, Baltimore D (1990) Activation in vitro of NF-kappa B by phosphorylation of its inhibitor I kappa B. Nature 344: 678-682.
56. DiDonato JA, Hayakawa M, Rothwarf DM, Zandi E, Karin M (1997) A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature 388: 548-554. (Pubitemid 27339997)
57. Regnier CH, Song HY, Gao X, Goeddel DV, Cao Z, et al. (1997) Identification and characterization of an IkappaB kinase. Cell 90: 373-383.
58. Stice JP, Mbai FN, Chen L, Knowlton AA (2012) Rapid activation of nuclear factor kB by 17b-estradiol and selective estrogen receptor modulators: pathways mediating cellular protection. Shock 38: 128-136.
59. Keshari RS, Verma A, Barthwal MK, Dikshit M (2013) Reactive oxygen species-induced activation of ERK and p38MAK mediates PMA-induced NETs release from human neutrophils. J Cell Biochem 114: 532-540.
60. Evans MJ, Eckert A, Lai K, Adelman SJ, Harnish DC (2001) Reciprocal antagonism between estrogen receptor and NF-kappaB activity in vivo. Circ Res 89: 823-830. (Pubitemid 34633854)
61. Harnish DC, Scicchitano MS, Adelman SJ, Lyttle CR, Karathanasis SK (2000) The role of CBP in estrogen receptor cross-talk with nuclear factor-kappaB in HepG2 cells. Endocrinology 141: 3403-3411. (Pubitemid 32269030)
62. Deshpande R, Khalili H, Pergolizzi RG, Michael SD, Chang MD (1997) Estradiol down-regulates LPS-induced cytokine production and NFkB activation in murine macrophages. Am J Reprod Immunol 38: 46-54. (Pubitemid 27308153)